U.S. NeuroSurgical Holdings
Financial ratios & Valuation

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
6.372.753.194.92-3.8810.973.94-2.65-0.54-5.11-0.37-3.88
Price/Sales ratio
1.370.360.530.770.470.500.661.68N/AN/AN/A0.50
Price/Book Value ratio
1.820.460.590.770.540.490.570.630.696.471.060.54
Price/Cash Flow ratio
3.760.941.251.120.711.001.8810.30-0.61-4.68-0.551.00
Price/Free Cash Flow ratio
-6.061.331.251.150.950.571.3710.30-0.39-4.68-0.550.57
Price/Earnings Growth ratio
-0.03-0.090.07N/A0.02-0.080.010.01-0.000.090.00-0.08
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
73.45%59.77%59.83%57.02%60.83%88.59%88.62%91.89%N/AN/AN/A88.59%
Operating Profit Margin
28.23%18.31%19.11%20.15%3.82%7.88%27.76%-8.38%N/AN/AN/A7.88%
Pretax Profit Margin
30.80%21.81%27.33%12.91%-17.90%4.91%26.97%-52.21%N/AN/AN/A-17.90%
Net Profit Margin
21.51%13.32%16.68%15.75%-12.29%4.62%16.79%-63.52%N/AN/AN/A-12.29%
Effective Tax Rate
30.13%38.88%38.95%-21.99%31.32%5.96%37.73%-21.66%-2.54%N/A3.07%5.96%
Return on Assets
7.52%5.36%6.50%6.79%-6.78%2.84%12.77%-18.27%-89.98%-61.77%-172.70%2.84%
Return On Equity
28.59%16.79%18.52%15.67%-13.98%4.50%14.46%-23.81%-126.87%-126.51%-123.22%4.50%
Return on Capital Employed
11.53%8.93%9.13%10.91%3.02%7.20%23.41%-2.64%-94.47%-107.14%-128.52%7.20%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A2.09N/A
Quick Ratio
1.421.421.932.462.151.637.336.855.550.861.931.63
Cash ratio
0.980.821.281.660.800.814.956.665.480.761.930.80
Days of Sales Outstanding
38.7883.78101.25100.07254.5642.3239.80N/AN/AN/AN/A42.32
Days of Inventory outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Cycle
38.7883.78101.25100.07254.5642.3239.80N/AN/AN/AN/A42.32
Days of Payables Outstanding
50.6324.4324.3351.7561.78265.92171.88717.26804.871.07KN/A265.92
Cash Conversion Cycle
-11.8559.3576.9148.31192.77-223.60-132.08-717.26N/AN/AN/AN/A
Debt Ratios
Debt Ratio
0.110.110.110.120.220.180.030.010.010.020.280.22
Debt Equity Ratio
0.410.360.320.280.460.290.030.010.010.040.470.46
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Total Debt to Capitalization
0.290.260.240.220.310.220.030.010.010.04N/A0.22
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cash Flow to Debt Ratio
1.151.331.452.411.631.658.654.04-61.43-33N/A1.65
Company Equity Multiplier
3.793.132.842.302.061.581.131.301.412.041.641.64
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
0.360.380.420.680.660.500.350.16N/AN/AN/A0.50
Free Cash Flow / Operating Cash Flow Ratio
-0.620.7010.980.751.751.3611.54110.75
Cash Flow Coverage Ratio
1.151.331.452.411.631.658.654.04-61.43-33N/A1.65
Short Term Coverage Ratio
1.151.331.452.411.631.658.654.04-61.43-33-41.441.65
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A